Aplex Bio
PrivateLast Round
Grant
Nov 2, 2023
Total Funding Raised
$1.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aplex Bio is a biotechnology company that develops hyperplexed PCR solutions for the detection of multiple biomarkers in a single sample.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aplex Bio Comparables
Compare Aplex Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Signal Bioscience | 78% | |
| ChromaCode | 78% | |
| YouSeq | 71% | |
Aplex Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 2, 2023 | ||||
| Seed | Mar 11, 2022 |
Aplex Bio Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 41% MoM, reaching 2K.
- Mar 1, 2026
Monthly visitors grew 877% MoM to 3.7K.
Aplex Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aplex Bio's valuation, stock price, and market status.